Forest and Deloitte to collaborate

Share this article:

ConvergeHEALTH by Deloitte has entered into a multi-year collaboration with Forest Labs and Intermountain Healthcare to conduct outcomes research. The collaboration will leverage next-generation analytics, insights from real-world evidence and collaborative research to better understand patient outcomes and success factors. Its initial focus is respiratory disease.

Launched in February, ConvergeHEALTH is Deloitte's business unit combining analytics products with the organization's consulting capabilities.

Dr. Shailja Dixit, executive director, HEOR, at Forest, said, “this collaboration has the potential to provide unique insights into respiratory disease.” The parties said they will leverage EMR data to help understand associated outcomes for treatments and filter for sub-populations using phenotypic characteristics and medical associations.

Share this article:
close

Next Article in Features

Email Newsletters

More in Features

Leadership Exchange: How Do We Get Beyond the Pill?

Leadership Exchange: How Do We Get Beyond the ...

As its focus moves from manufacturing to service, pharma needs to partner with healthcare neophytes as well as established players. James Chase asks six experts to assess the risks and ...

FDA and off-label uses: a balancing act

FDA and off-label uses: a balancing act

FDA's current re-examination of its off-label promotion policies in light of the First Amendment is a delicate balancing act between its rock-solid traditional enforcement posture and a diverse new electronic ...

Read the complete August 2014 Digital Edition

Read the complete August 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.